ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Carlos F. Barbas III is among the recipients of the 2010 National Institutes of Health Director’s Pioneer Awards, which provide up to $500,000 in research funding for five years. The award supports exceptionally creative scientists who take innovative approaches to major challenges in biomedical research.
Barbas is Janet & Keith Kellogg II Chair in Molecular Biology and a chemistry professor at Scripps Research Institute. His research will focus on chemically programming immunity, which could lead to “instant immunity” vaccines for the flu, HIV-1, and cancer. The new approach may help overcome the lag time that current vaccinations take to build the body’s immunity against pathogens.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter